Paper Details

  1. Home
  2. Paper Details

Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).

Author: AlfonsoEduardo, SchlechBarry A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

The fourth-generation ophthalmic fluoroquinolones include moxifloxacin (VIGAMOX, Alcon Laboratories, Inc., Fort Worth, TX) and gatifloxacin (Zymar, Allergan, Irvine, CA), and they are now approved for the treatment of bacterial conjunctivitis.
Paper Details　
Original Abstract of the Article :
Antibiotics have been the mainstay of therapy for infectious diseases since their origins in the 1940s. As microorganisms changed and resistance developed, more advanced antibiotics were ultimately needed to provide adequate coverage and spectrum. By selecting optimal antibiotics and dosing regimens...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.survophthal.2005.05.002

データ提供：米国国立医学図書館（NLM）

Moxifloxacin Ophthalmic Solution: A Potent Weapon in the Desert of Eye Infections

Bacterial infections of the eye can be a serious concern, causing pain, discomfort, and potential vision loss. This study reviews the efficacy and safety of moxifloxacin ophthalmic solution (VIGAMOX) in the treatment of bacterial conjunctivitis. The authors discuss the potency of moxifloxacin and its potential advantages over older fluoroquinolones.

Moxifloxacin: A Powerful Weapon in the Desert of Eye Infections

The authors highlight the in vitro and in vivo evidence supporting the effectiveness of moxifloxacin against gram-positive and gram-negative bacteria. They conclude that moxifloxacin is a potent and effective treatment for bacterial conjunctivitis and may be a preferred option for the prevention and treatment of more serious ophthalmic infections.

Navigating the Desert of Eye Health

The study's findings provide valuable insights for ophthalmologists and other healthcare providers treating bacterial conjunctivitis. Moxifloxacin may be a valuable tool in their arsenal, offering a potent and effective solution for these common infections.

Dr.Camel's Conclusion

Bacterial eye infections can be a real desert storm, causing discomfort and potential vision loss. This review sheds light on the potency of moxifloxacin ophthalmic solution, suggesting that it can be a powerful weapon in the battle against these infections. However, as always, responsible medication use and consultation with a healthcare professional are essential for ensuring optimal eye health.

Date :
  1. Date Completed 2006-01-03
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

16257313

DOI: Digital Object Identifier

10.1016/j.survophthal.2005.05.002

Related Literature

Article Analysis
・Effects of moxifloxacin ophthalmic
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.